This inventor holds 1 USPTO granted patent. Top assignee: The University of Texas System. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Innovations in Precision Oncology by Kristine Yang
Introduction
Kristine Yang is a notable inventor based in Houston, Texas. She has made significant contributions to the field of precision oncology through her innovative research and development of pharmaceutical compounds. Her work focuses on the inhibition of enolase enzymes, which play a crucial role in cancer treatment.
Latest Patents
Kristine Yang holds 1 patent for her invention titled "Inhibitors of the enzyme enolase for precision oncology." This patent provides compounds that can inhibit enolase enzymes, offering potential therapeutic benefits in oncology. The disclosure includes pharmaceutical compositions comprising these compounds and methods of treatment utilizing them.
Career Highlights
Kristine is affiliated with the University of Texas System, where she conducts her research. Her work has garnered attention for its potential impact on cancer therapies, showcasing her dedication to advancing medical science.
Collaborations
Some of her notable coworkers include Florian Muller and Victoria Yan, who contribute to her research efforts and collaborative projects.
Conclusion
Kristine Yang's innovative work in precision oncology exemplifies the importance of research in developing effective cancer treatments. Her contributions are paving the way for future advancements in the field.